Skip to main content

neuromodulation

By Adam Ang | 04:58 am | June 06, 2025
It has shown potential to significantly reduce pain intensity.
By Jessica Hagen | 05:04 pm | March 12, 2025
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
By Jessica Hagen | 02:38 pm | December 13, 2024
The company will use the funds to accelerate the development of its Ellipse Spinal Cord Stimulator Platform, used to treat chronic pain.
By Jessica Hagen | 12:20 pm | March 27, 2023
The company's product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response.
By Adam Ang | 03:52 am | April 13, 2022
The digital platform enables clinicians to adjust their patient's devices remotely and in real-time.
By Dave Muoio | 03:25 pm | March 10, 2021
The startup will now move onto a larger pivotal trial of the neuromodulation therapy, which received a Breakthrough Device Designation from the FDA in January.
By Dave Muoio | 02:38 pm | March 08, 2021
Providers will be able to have in-app live video conversations with chronic pain and movement disorder patients, as well as prescribe new settings for their neuromodulation therapies from afar.
By Dave Muoio | 03:56 pm | July 24, 2020
The Patient Controller app works with Abbott's Infinity DBS System, Proclaim XR SCS System and Proclaim DRG Neurostimulation System.
By Jonah Comstock | 12:38 pm | December 14, 2015
Samsung and Medtronic are once again teaming up, this time to build mobile tools for patients using neuromodulation therapy, a treatment used in a number of chronic conditions including chronic pain, movement disorders, and incontinence.